Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
NCT00501241
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
214
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Constipation
Interventions
DRUG:
ATI-7505
DRUG:
ATI-7505
DRUG:
ATI-7505
DRUG:
ATI-7505
DRUG:
ATI-7505
Sponsor
Procter and Gamble